| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Collaboration revenue | 1,594 | 765 | 8,723 | 7,554 |
| Research and development | 21,630 | 15,499 | 15,357 | 15,088 |
| General and administrative | 12,162 | 7,668 | 8,834 | 9,181 |
| Loss on lease termination | 25,490 | -514 | -1,138 | -1,169 |
| Total operating expenses | 8,302 | 23,681 | 25,329 | 25,438 |
| Loss from operations | -6,708 | -22,916 | -16,606 | -17,884 |
| Nonoperating income (expense) | - | - | - | 2,571 |
| Other income and interest income, net | 1,188 | 1,993 | 1,804 | - |
| Net loss | -5,520 | -20,923 | -14,802 | -15,313 |
| Unrealized losses on marketable securities | 4 | -81 | -74 | 599 |
| Comprehensive loss | -5,516 | -21,004 | -14,876 | -14,714 |
| Earnings per share, basic | -0.82 | -3.12 | -0.22 | -0.23 |
| Earnings per share, diluted | -0.82 | -3.12 | -0.22 | -0.23 |
| Weighted average number of shares outstanding, basic | 6,735,454 | 6,703,586 | 67,002,511 | 66,738,468 |
| Weighted average number of shares outstanding, diluted | 6,735,454 | 6,703,586 | 67,002,511 | 66,738,468 |
Generation Bio Co. (GBIO)
Generation Bio Co. (GBIO)